Can Wellbutrin (bupropion) at 300 mg daily for depression cause heat intolerance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Wellbutrin Cause Heat Intolerance?

Bupropion (Wellbutrin) at 300 mg daily does not cause heat intolerance and is not associated with thermoregulatory dysfunction. In fact, a pilot study specifically evaluated bupropion for treating hot flashes and found it ineffective, which is consistent with its mechanism of action—norepinephrine and dopamine reuptake inhibition without serotonergic effects. 1

Evidence Against Heat Intolerance

  • A 2006 pilot study directly tested bupropion's effect on hot flashes in 21 patients (7 men, 14 women) using 150 mg twice daily for 4 weeks. The study showed no reduction in hot flash frequency or severity beyond placebo expectations, suggesting bupropion does not interfere with thermoregulation. 1

  • The mechanism of action argues against heat intolerance. Bupropion inhibits norepinephrine and dopamine reuptake without serotonergic activity. 1, 2 Hot flashes and heat intolerance are hypothesized to result from increased noradrenergic activity and decreased serotonergic activity—bupropion's norepinephrine reuptake inhibition would theoretically worsen, not cause, such symptoms, yet this is not observed clinically. 1

Documented Side Effect Profile

  • Large-scale safety data from multiple trials show no heat intolerance. Common adverse effects of bupropion include insomnia, dry mouth, headache, nausea, tremor, and sweating—but not heat intolerance or thermoregulatory problems. 3, 4, 5

  • Cardiovascular effects are limited to blood pressure elevation. Bupropion can cause modest increases in blood pressure and heart rate, particularly in the first 12 weeks of treatment, but does not produce heat intolerance as a cardiovascular side effect. 3, 6

  • Historical safety studies confirm absence of thermoregulatory effects. A 1991 study of 36 depressed patients with preexisting heart disease treated with bupropion (mean dose 442 mg/day) documented cardiovascular parameters extensively but reported no heat intolerance or temperature regulation issues. 6

Clinical Monitoring Recommendations

  • Monitor blood pressure and heart rate periodically during the first 12 weeks of treatment, as bupropion can elevate both parameters—but this does not translate to heat intolerance. 3

  • Common activating side effects include agitation, restlessness, and insomnia, which should be monitored, particularly when dosing later in the day. 3 These are distinct from thermoregulatory dysfunction.

Alternative Explanations to Consider

If a patient on bupropion 300 mg daily reports heat intolerance, investigate:

  • Concurrent medications that genuinely cause heat intolerance (anticholinergics, antihistamines, beta-blockers)
  • Underlying medical conditions (hyperthyroidism, autonomic dysfunction, menopausal symptoms in women)
  • Environmental factors or dehydration
  • Anxiety or panic symptoms that may be misinterpreted as heat intolerance

The evidence strongly indicates that bupropion does not cause heat intolerance at therapeutic doses, including 300 mg daily for depression. 1, 2, 4, 5, 6

References

Research

Pilot evaluation of bupropion for the treatment of hot flashes.

Journal of palliative medicine, 2006

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A double-blind study of bupropion and placebo in depression.

The American journal of psychiatry, 1984

Related Questions

Should I increase my Wellbutrin (bupropion) dose from 150 mg for depression and anxiety, and what other interventions can I use to manage worsening anxiety and stress?
Is Wellbutrin (bupropion) effective for treating anxiety in adult patients with comorbid depression?
What is the appropriate next step in management for a 32‑year‑old female on Wellbutrin (bupropion) and Vyvanse (lisdexamfetamine) 20 mg who has persistent irritability and easy anger and may have bipolar disorder?
In an 80‑year‑old patient taking Wellbutrin (bupropion) 300 mg daily who remains depressed and anxious after increasing from 150 mg, should the bupropion dose be increased further or should an augmenting medication be added?
A 36-year-old woman with ADHD and depression who is taking bupropion (Wellbutrin XL) 300 mg daily presents with new onset irritability; what is the appropriate management?
A patient recently treated for streptococcal pharyngitis now presents with a new episode; what is the recommended first‑line antibiotic regimen, and what alternatives should be used if there is a confirmed penicillin allergy?
What are the recommended medications for managing vasospasm, including cerebral vasospasm after subarachnoid hemorrhage and coronary or peripheral vasospasm?
What is the significance and appropriate evaluation for a patient with a white‑blood‑cell count of 11.5 ×10⁹/L and an anion‑gap of 17 mEq/L?
Can ipratropium bromide be used in a patient with glaucoma?
Do oxycodone, gabapentin, baclofen, or hydroxyzine cause involuntary muscle twitching (myoclonus or fasciculations)?
What is mild generalized edema?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.